When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JAZZ - Enrollment underway in study of Jazz Pharma's JZP-458 in blood cancers
Jazz Pharmaceuticals plc
The first participant has been enrolled in an open-label Phase 2/3 clinical trial evaluating Jazz Pharmaceuticals' (NASDAQ:JAZZ) JZP-458 in pediatric and adult patients with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL) who are hypersensitive to E. coli-derived enzymes called asparaginases, a Fast Track-tagged indication in the U.S.
More news on: Jazz Pharmaceuticals plc, Healthcare stocks news,